Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy
Cellular immunotherapy has attracted increasing interest in genetic modification of immunologically competent cells in order to activate the effector cell after binding to predefined antigen. The chimeric immune-receptor strategy utilizes recombinant receptor molecules that are grafted on the surface of effector cells and comprise an extracellular antigen-binding domain and an intracellular signaling domain. The antigen-binding domain is a scFv (single-chain fragment of variable regions) derived from an antibody and is fused to a transmembrane moiety and an intracellular signaling domain that mediates cellular activation upon receptor crosslinking by binding of the scFv domain to antigen. This design of a chimeric receptor molecule combines the specific binding to predefined ligands with the initiation of intracellular signaling pathways for cellular activation (1 ).
- Gene Amplification of c-erbB-2 Detected by FISH
- Fluorescence In Situ Hybridization to Chromosomes
- Demonstration of a Germinal Center Immunophenotype in Lymphomas by Immunocytochemistry and Flow Cytometry
- Cancer Gene Profiling in Prostate Cancer
- Cytogenetic Studies in Hematologic Malignancies: An Overview
- Immunohistochemical Analysis for hMLH1 and hMSH2 Expression in Colorectal Cancer
- Role of Tumor Suppressors in DNA Damage Response
- 检测RAS、MAPK、p38、p21
- 用24孔板做过成骨细胞的钙结节染色计数
- 细胞组分的分析方法